Inbiogen

인바이오젠 · 101140

Industrials Trading & Distribution · KOSPI

Small-cap

Market cap US$54.8M (₩75.6B)

Overview

Inbiogen distributes self-service kiosk terminals, the standalone touchscreen machines used for unattended payments and ordering, and operates a food-and-beverage business.

Its kiosk products serve businesses and venues that want to automate customer transactions without a cashier. The company is listed on KOSPI, South Korea's main stock exchange, and is classified as a small and medium-sized enterprise under Korean regulations. Its two business lines, kiosk distribution and food and beverage, form the entirety of its current operations.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$4.6M

▼ −10.6% YoY

Operating profit · FY2025

−US$3.1M

Loss narrowed

Net income · FY2025

−US$1M

Turned to loss

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$4.5M(₩6.2B)	US$5.1M(₩7B)	US$4.6M(₩6.3B)
Operating profit	−US$4.5M(−₩6.2B)	−US$4.4M(−₩6.1B)	−US$3.1M(−₩4.3B)
Net income	US$8.2M(₩11.3B)	US$11.7M(₩16.1B)	−US$1M(−₩1.4B)

Revenue

FY2023US$4.5M
FY2024US$5.1M
FY2025US$4.6M

Operating profit

FY2023−US$4.5M
FY2024−US$4.4M
FY2025−US$3.1M

Net income

FY2023US$8.2M
FY2024US$11.7M
FY2025−US$1M

Key ratios (FY2025)

ROE

-0.9%

Debt/Eq

1.5%

Op. margin

-68.8%

Net margin

-22.5%

Rev. YoY

▼ −10.6%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?